Gerard Matysik, DO
Pulmonary Disease Physician in Pella, Iowa. This profile is drawn from the federal National Provider Identifier Registry (CMS NPPES), which lists more than 7 million U.S. healthcare providers - including 9,271 in Pulmonary Disease Physician, and covers specialty classification, practice address, and Medicare Part D prescribing data when reported. According to CMS, every field reflects the provider's official federal registration, see our methodology.
Source: CMS Medicare Part D Prescriber Public Use File, 2023
What the federal data shows
Gerard Matysik, DO reported a CMS MIPS final score of 81.6/100 - below the 83.1 national average - and filed 1,077 Medicare Part D claims in 2023.
- 81.6/100
- MIPS score · -1 vs avg
- 1K
- Part D claims, 2023
- 26%
- generic prescribing
- Likely
- board-certified (heuristic)
Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) - no proprietary rating or editorial opinion is applied.
Gerard Matysik, DO's MIPS score vs every scored U.S. clinician
CMS Merit-based Incentive Payment System (MIPS) final score, 2023, the federal quality measure
82 36th percentile higher than 36% of 477,587 scored providers
Each bar is a band; taller bars hold more scored providers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source CMS Merit-based Incentive Payment System (MIPS) · 2023
Where Gerard Matysik, DO sits
This provider among pulmonary disease physician peers
Across the 2,676 pulmonary disease physician providers who report both Medicare Part D prescribing and a MIPS quality score, Gerard Matysik, DO writes more Part D claims than 49% of them and scores higher on MIPS quality than 43% - placing this provider in the lower-volume, lower-quality quadrant. Volume reflects patient-panel size and specialty, not quality; the two axes are independent.
Part D claim volume vs MIPS quality, by specialty percentile
Each dot is one pulmonary disease physician peer from a representative sample of 60; the gold marker is Gerard Matysik, DO. Source: CMS Medicare Part D Prescriber data and the CMS Merit-based Incentive Payment System, 2023.
Gerard Matysik, DO practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + MIPS quality reporting - signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).
What does the federal data show about Gerard Matysik, DO?
Near national averagePrimary specialty
Medicare Part D claims
MIPS final score
Specialty distribution in Iowa
How Pulmonary Disease Physician compares to other specialties among Iowa providers
Largest specialties in Iowa (% of in-state providers)
Pulmonary Disease Physician ranks #83 among Iowa's specialties (0.1% of in-state providers)
Each bar is a specialty's share of the Iowa provider total, by primary NUCC taxonomy. The highlighted bar is Pulmonary Disease Physician; the long tail of smaller specialties is omitted for legibility.
Medicare quality performance, MIPS
Gerard Matysik, DO's 2023 MIPS final score plotted against the Pulmonary Disease Physician national average
- MIPS Final Score
- 81.6/100
- vs 83.1 national avg · 2023 performance year
MIPS final score (Pulmonary Disease Physician) - 81.6/100 vs national avg 83.1
Quality benchmarks
- National MIPS avg 2023 reporting year
- Quality dim CMS Quality category
- Cost dim CMS Cost category
- Specialty volume Pulmonary Disease Physician US NPIs
81.6/100 MIPS final score - 1.5 pts below the 83.1 national average
Quality, Cost, Promoting Interoperability, and Improvement Activities composite score for the 2023 performance year. Specialty: Pulmonary Disease Physician. Quality dim: 87.6. Cost dim: 51.1.
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
Gerard Matysik, DO appears in the CMS NPPES registry as a Pulmonary Disease Physician provider holding DO credentials at 405 MONROE ST, Pella, IA, 50219, with a listed phone of (641) 621-2200. NPI 1750367124 was issued on 12/19/2005. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what Matysik most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.
Medicare Part D records for calendar year 2023 show 1,077 prescription claims written by this provider, covering 140 Medicare beneficiaries and totaling roughly $577K in drug spend, split 73% brand-name and 26% generic by claim count. These figures capture only Medicare Part D, commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy. On the CMS Merit-based Incentive Payment System, this provider earned a Final Score of 81.6/100 for the 2023 performance year (Quality 87.6, Cost 51.1), compared with the national average of 83.1.
Pulmonary Disease Physician is a mid-sized specialty nationwide, with 9,271 enrolled providers across 53 states and an average of 1,457 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist, always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.
Practice Address
Provider Details
| NPI | 1750367124 |
|---|---|
| Specialty | Pulmonary Disease Physician |
| Credentials | DO |
| Gender | Male |
| NPI Issued | 12/19/2005 |
Verify this provider's license
PlainDoctor pulls this profile from the CMS NPPES public registry. Confirm Gerard Matysik, DO's current license status, disciplinary history, and board certifications with the Iowa Board of Medicine in Iowa before relying on this page for a clinical or care decision.
How we sourced this profile
CMS Quality Score (MIPS)
Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.
Reporting: Group practice
Brand vs generic prescribing mix · Brand-heavy
73% brand-name claims vs 26% generic, on 1,077 2023 Medicare Part D claims.
The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2023.
Prescribing Breakdown
- 30-Day Fills
- 1,383
- Total Day Supply
- 38,928
- Brand vs Generic
- 73% brand / 26% generic
- Brand Drug Cost
- $565K
- Generic Drug Cost
- $11K
Patient Demographics
- Average Patient Age
- 72.6 years
- Avg HCC Risk Score
- 1.64
- Gender Split
- 54% female / 46% male
- Age Distribution
- <65: 26, 65-74: 56, 75-84: 45, 85+: 13
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.
What Gerard Matysik, DO prescribes most
Top Medicare Part D drugs by claim count, 2023
- Anoro Ellipta
Anoro Ellipta
185 claims
- Albuterol Sulfate …
Albuterol Sulfate Hfa
116 claims
- Breo Ellipta
Breo Ellipta
90 claims
- Trelegy Ellipta 52
Trelegy Ellipta
52 claims
- Fluticasone-Salmet… 43
Fluticasone-Salmeterol
43 claims
- Advair Hfa 41
Advair Hfa
41 claims
- Advair Diskus 39
Advair Diskus
39 claims
- Spiriva Respimat 39
Spiriva Respimat
39 claims
| Drug | Claims |
|---|---|
| Anoro Ellipta Umeclidinium Brm/Vilanterol Tr | 185 |
| Albuterol Sulfate Hfa Albuterol Sulfate | 116 |
| Breo Ellipta Fluticasone/Vilanterol | 90 |
| Trelegy Ellipta Fluticasone/Umeclidin/Vilanter | 52 |
| Fluticasone-Salmeterol Fluticasone Propion/Salmeterol | 43 |
| Advair Hfa Fluticasone Propion/Salmeterol | 41 |
| Advair Diskus Fluticasone Propion/Salmeterol | 39 |
| Spiriva Respimat Tiotropium Bromide | 39 |
| Combivent Respimat Ipratropium/Albuterol Sulfate | 34 |
| Flovent Hfa Fluticasone Propionate | 30 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
Pulmonary Disease Physician Overview
How Gerard Matysik, DO fits within the Pulmonary Disease Physician landscape nationally.
Gerard Matysik, DO's 1,077 claims are below the specialty average of 1,457.
Nearby Pulmonary Disease Physician Providers in Iowa
Other clinicians with the same primary specialty enrolled in Iowa, drawn from the same CMS NPPES roster as Matysik.
Compare Pulmonary Disease Physician nationally: see state-by-state distribution →
Before you book an appointment
Use this federal record as your verification checklist, not as a recommendation.
- Confirm the NPI record is current in the official CMS registry, providers update their own NPPES details, and moves can lag. Verify this NPI
- Check the active license and any disciplinary history with the Iowa medical board, federal registration is not a license check. Credential verification guide
- Weigh a second option: compare this provider with a nearby Pulmonary Disease Physician peer on Medicare volume and prescribing patterns. Compare providers
Medicare Part D and MIPS figures describe practice patterns in federal programs only, they are not quality ratings, and PlainDoctor does not rate, rank, or recommend providers.
Healthcare Guides
Learn more about finding, verifying, and understanding healthcare providers.
Explore Iowa
Frequently Asked Questions
What is Gerard Matysik, DO's specialty? ▼
How much does Gerard Matysik, DO prescribe under Medicare Part D? ▼
What is Gerard Matysik, DO's Medicare quality score? ▼
Where is Gerard Matysik, DO located? ▼
What is Gerard Matysik, DO's NPI number? ▼
Does Gerard Matysik, DO prescribe more brand-name or generic drugs? ▼
How many Pulmonary Disease Physician providers are there in the US? ▼
What drugs does Gerard Matysik, DO prescribe most often? ▼
Does Gerard Matysik, DO accept Medicare? ▼
How can I verify Gerard Matysik, DO's credentials? ▼
Data Sources
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Quality Performance
- CMS Merit-based Incentive Payment System (MIPS) - 2023 performance year.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology